Zhao-Shen Li Selected Research

Chronic Pancreatitis

1/2022	Rectal indometacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): a single-centre, double-blind, randomised, placebo-controlled trial.
8/2021	SPINK1 mutations and risk of pancreatic cancer in a Chinese cohort.
4/2020	Comments on the study comparing multiple stents and single stent insertion for chronic pancreatitis.
4/2020	Characterization of CEL-DUP2: Complete duplication of the carboxyl ester lipase gene is unlikely to influence risk of chronic pancreatitis.
3/2020	Fibromodulin is upregulated by oxidative stress through the MAPK/AP-1 pathway to promote pancreatic stellate cell activation.
1/2020	Meta-analysis of the impact of the SPINK1 c.194 + 2T > C variant in chronic pancreatitis.
1/2020	Corrigendum to "Dasatinib ameliorates chronic pancreatitis induced by caerulein via anti-fibrotic and anti-inflammatory mechanism" [Pharmacol Res. 147 (2019) 104357].
1/2020	Isoliquiritigenin ameliorates caerulein-induced chronic pancreatitis by inhibiting the activation of PSCs and pancreatic infiltration of macrophages.
12/2019	Toward a clinical diagnostic pipeline for SPINK1 intronic variants.
2/2019	Autoantibody detection is not recommended for chronic pancreatitis: a cross-sectional Study of 557 patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhao-Shen Li Research Topics

Disease

38	Chronic Pancreatitis 01/2022 - 03/2004
24	Pancreatic Neoplasms (Pancreatic Cancer) 08/2021 - 02/2003
23	Neoplasms (Cancer) 01/2021 - 04/2003
21	Shock 05/2022 - 11/2012
17	Pancreatitis 05/2022 - 01/2007
8	Infections 02/2022 - 11/2006
7	Adenocarcinoma 11/2020 - 06/2009
7	Inflammation (Inflammations) 01/2020 - 10/2011
5	Fibrosis (Cirrhosis) 01/2020 - 10/2011
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 08/2019
4	Pathologic Constriction (Stenosis) 01/2020 - 02/2006
4	Pain (Aches) 08/2015 - 01/2011
3	Steatorrhea 09/2021 - 02/2016
3	Stomach Diseases 01/2021 - 06/2015
3	Autoimmune Pancreatitis 01/2021 - 08/2010
3	Carcinogenesis 01/2021 - 10/2010
3	Acute Necrotizing Pancreatitis 06/2020 - 01/2008
3	Necrosis 01/2020 - 01/2008
3	Adenoma (Adenomas) 02/2019 - 03/2012
3	Hemorrhage 01/2019 - 10/2015
3	Neoplasms, Cystic, Mucinous, and Serous 05/2018 - 06/2009
3	Disease Progression 04/2016 - 09/2015
3	Hepatitis B 08/2015 - 06/2009
3	Hyperamylasemia 05/2015 - 01/2007
2	Cysts 05/2022 - 02/2006
2	Abdominal Pain (Pain, Abdominal) 05/2022 - 08/2020
2	COVID-19 02/2022 - 02/2022
2	Hematoma 12/2019 - 11/2018
2	Pancreatic Diseases (Pancreatic Disease) 10/2018 - 03/2004
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2016
2	Pancreatic Pseudocyst 07/2016 - 01/2013
2	Alcoholism (Alcohol Abuse) 04/2016 - 02/2016
2	Peptic Ulcer (Peptic Ulcers) 11/2015 - 03/2007
2	Hypersensitivity (Allergy) 08/2015 - 04/2008
2	Gastritis 02/2014 - 08/2012
2	Dyspepsia (Indigestion) 08/2013 - 03/2007
2	Sepsis (Septicemia) 09/2010 - 03/2009
2	Cholangiocarcinoma 03/2010 - 11/2008
2	Ulcer 03/2007 - 06/2006
1	Constipation 05/2022
1	Autosomal Dominant Polycystic Kidney (ADPKD) 05/2022
1	Obstructive Jaundice (Cholestatic Jaundice) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	Flushing 09/2020
1	Esophageal Squamous Cell Carcinoma 01/2020

Drug/Important Bio-Agent (IBA)

12	Capsules (Microcapsules)IBA 05/2022 - 03/2009
11	Kazal Pancreatic Trypsin InhibitorIBA 09/2021 - 01/2013
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2010
5	EnzymesIBA 01/2022 - 02/2003
5	CeruletideIBA 01/2022 - 01/2013
4	Proteins (Proteins, Gene)FDA Link 09/2020 - 11/2006
4	MicroRNAs (MicroRNA)IBA 11/2017 - 01/2012
4	Messenger RNA (mRNA)IBA 05/2017 - 10/2010
4	DNA (Deoxyribonucleic Acid)IBA 08/2015 - 06/2009
3	SteroidsIBA 01/2021 - 12/2013
3	AcidsIBA 08/2020 - 06/2006
3	Lipase (Acid Lipase)FDA Link 04/2020 - 09/2010
3	Therapeutic UsesIBA 01/2019 - 03/2007
3	Immunoglobulin G (IgG)IBA 12/2014 - 08/2010
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2013 - 11/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2010 - 01/2008
3	Codon (Codons)IBA 05/2004 - 05/2003
2	Indomethacin (Indometacin)FDA LinkGeneric 01/2022 - 11/2017
2	EstersIBA 04/2020 - 01/2016
2	Dasatinib (BMS 354825)FDA Link 01/2020 - 01/2019
2	PlasticsIBA 01/2020 - 10/2018
2	MetalsIBA 01/2020 - 10/2018
2	Simethicone FDA Link 02/2019 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2018
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 03/2007
2	Small Interfering RNA (siRNA)IBA 01/2016 - 10/2010
2	VimentinIBA 09/2014 - 03/2013
2	Iodine-125IBA 11/2012 - 01/2011
2	Octreotide (Sandostatin)FDA LinkGeneric 10/2008 - 01/2007
2	DNA VaccinesIBA 02/2007 - 11/2006
2	Cytosine DeaminaseIBA 04/2003 - 02/2003
1	Glycerol (Glycerine)FDA LinkGeneric 01/2022
1	Suppositories (Vaginal Suppositories)IBA 01/2022
1	Corticotropin-Releasing HormoneIBA 12/2021
1	Extracellular Matrix ProteinsIBA 01/2021
1	C-Reactive ProteinIBA 06/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2020
1	Blood Glucose (Blood Sugar)IBA 06/2020
1	CreatinineIBA 06/2020
1	FibromodulinIBA 03/2020
1	isoliquiritigenin (GU 17)IBA 01/2020

Therapy/Procedure

21	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 05/2022 - 11/2012
16	Therapeutics 09/2021 - 03/2007
11	Stents 04/2020 - 02/2006
4	Endoscopic Sphincterotomy 01/2019 - 02/2006
2	Contraindications 05/2022 - 02/2019
2	Injections 01/2022 - 01/2013
2	Pancreatectomy 04/2016 - 03/2011
2	Endoscopes 10/2015 - 01/2011
2	Brachytherapy 10/2013 - 01/2011
2	Photochemotherapy (Photodynamic Therapy) 03/2010 - 11/2008
2	Drug Therapy (Chemotherapy) 03/2010 - 04/2003
1	Aftercare (After-Treatment) 05/2022
1	Immunotherapy 01/2021
1	Esophagectomy 01/2020